Skip to main content
logo
Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada flag Canada · Delayed Price · Currency is CAD
11.30
-0.15 (-1.31%)
Sep 24, 2026, 10:54 AM EST

Eupraxia Pharmaceuticals Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7555231611477935
Market Cap Growth
136.58%225.34%9.66%85.89%125.87%-
Enterprise Value
6074411471275810
Last Close Price
11.4510.324.515.373.652.45

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.104.743.51124.328.081.83
P/TBV Ratio
5.227.2965.7050.067.481.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.0011.711.250.52
Net Debt / Equity Ratio
-1.02-1.00-1.04-9.96-1.29-1.04
Net Debt / EBITDA Ratio
2.322.101.230.320.531.12
Net Debt / FCF Ratio
3.452.761.100.430.631.31
Quick Ratio
15.7114.4410.741.016.0013.38
Current Ratio
16.0015.1211.101.026.0813.49
Return on Equity (ROE)
-66.70%-68.76%-157.31%-715.19%-178.04%-
Return on Assets (ROA)
-43.66%-39.67%-61.14%-88.37%-52.20%-68.51%
Return on Capital Employed (ROCE)
-43.50%-47.70%-84.80%-3120.70%-109.70%-61.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.91%-10.12%-22.84%-25.44%-31.75%-68.66%
FCF Yield
-7.19%-7.64%-26.96%-18.77%-25.12%-43.73%
Buyback Yield / Dilution
-47.80%-17.76%-40.52%-25.21%-55.45%-102.75%